A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)

Clinical trial NCT07286175 · RECRUITING

Trial details

NCT number: NCT07286175
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2025-11-24
Primary completion: 2027-11-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.